ABGABEVORRICHTUNG

Patent europeic · EP2847096 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2847096
Numer da la dumonda
EP13721757
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
09-05-2013
Publitgà
18-03-2015
Concedì
16-03-2016
Stritgà
23-12-2021
Motiv
Taxa annuala betg pajada
Classas IPC
B65D 83/04 (2006.01)
B65D 83/06 (2006.01)
Prioritad
EP 12167791 11.05.2012
Dumonda PCT
PCT/EP2013/059691 09.05.2013
Publicaziun PCT
WO2013/167715 14.11.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-12-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.12.2021

  2. 16-05-2020

    Represchentant inscrit

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 16.05.2020

  3. 16-05-2020

    Transferì

    Owner
    Novartis AG, Lichtstrasse 35, 4056 Basel → Phillips-Medisize A/S, Gimsinglundvej 20, 7600 Struer, Denmark

    Published in Swissreg on 16.05.2020

  4. 16-03-2016

    Concedì

    Published in Swissreg on 16.03.2016

Partidas

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.